↓ Skip to main content

Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice

Overview of attention for article published in Frontiers in Cardiovascular Medicine, December 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
8 Mendeley